Cowen AND Company LLC purchased a new position in shares of Lexaria Bioscience Corp. (NASDAQ:LEXX – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 256,327 shares of the company’s stock, valued at approximately $320,000. Cowen AND Company LLC owned about 2.46% of […]
Lexaria Bioscience Corp. (NASDAQ:LEXX – Free Report) – Research analysts at Zacks Small Cap lifted their FY2024 earnings estimates for shares of Lexaria Bioscience in a research report issued on Monday, April 29th. Zacks Small Cap analyst J. Vandermosten now anticipates that the company will earn ($0.46) per share for the year, up from their […]
Lexaria Bioscience (NASDAQ:LEXX – Get Free Report) and Adial Pharmaceuticals (NASDAQ:ADIL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership. Analyst Recommendations This is a summary of […]
Lexaria Bioscience (NASDAQ:LEXX – Get Free Report) and Edesa Biotech (NASDAQ:EDSA – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, institutional ownership and dividends. Volatility & Risk Lexaria Bioscience has a […]
Invenomic Capital Management LP raised its stake in Lexaria Bioscience Corp. (NASDAQ:LEXX – Free Report) by 62.0% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 766,573 shares of the company’s stock after buying an additional 293,470 shares during the quarter. Invenomic Capital Management LP owned approximately 9.48% […]